The observation that partial reduction in Cdc14 activity severely impairs pathogenesis in animal models of invasive candidiasis suggests that Cdc14 might be a useful antifungal drug target where even modest therapeutic inhibition of activity could successfully combat infections. The gene discussed is CDC14A; the disease is infection.